Search results
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 42 minutes agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
AstraZeneca withdraws COVID-19 vaccine citing low demand
KCCI 8 Des Moines· 2 hours agoAstraZeneca is withdrawing its highly successful coronavirus vaccine, citing the availability of a...
A 'Decline in Demand' Leads to the End for This COVID Vaccine
newser· 25 minutes agoMore than 3 billion doses of the vaccine were administered in other countries around the world...
AstraZeneca withdraws Covid-19 jab from the market
PA Media: Science via Yahoo News· 3 hours ago“The key reason for the withdrawal is likely to be that other Covid vaccines, such as Pfizer and Moderna, are essentially better products ...
Covid Vaccine Side Effects: 4 Takeaways From Our Investigation
New York Times· 5 days agoThousands of Americans believe they experienced rare but serious side effects. Apoorva Mandavilli...
AstraZeneca’s COVID vaccine withdrawn – right to the end it was the victim of misinformation
The Conversation· 12 hours agoThe Oxford-AstraZeneca vaccine was a critical part of the COVID-19 pandemic response. This EU announcement was preceded by an application from AstraZeneca ...
Two possible bird flu vaccines could be available within weeks, if needed
NBC News via Yahoo News· 7 days agoThe U.S. has two vaccines ready that could begin shipping widely within a few weeks if the H5N1 bird...
Why the WHO's Pandemic Treaty Should Set Off Your Alarm
Mercola· 11 hours agoThroughout COVID-19, the more money countries spent complying with the WHO’s guidelines for mitigating COVID-19, the more people died.1 Because of this, ...
Moderna Q1 earnings: lower-than-expected loss of $1.18 billion sets tone for vaccine launch | Invezz
Invezz· 6 days agoModerna Inc (NASDAQ: MRNA) reported a narrower-than-expected loss for the first quarter of the year,...